President Donald Trump and his administration downsized US science by historic margins last year as it reduced the workforce at federal research agencies by tens of thousands of people and terminated ...

A risk-taking outsider, he brought speed, competition and controversy to one of science’s biggest races. By Nicholas Wade J. Craig Venter, a scientist and entrepreneur who raced to decode the human ...

Season 1 of “R.J. Decker” comes to an end on Tuesday, April 28, but is the crime drama getting more episodes? “R.J. Decker” hasn’t been renewed for season 2 but it hasn’t been canceled either. There’s ...

It’s not just small talk, it’s all talk that’s dying. It’s not just small talk, it’s all talk that’s dying. is the Verge’s weekend editor. He has over 18 years of experience, including 10 years as ...

Katelyn is a reporter with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...

OpenAI on Thursday released GPT-5.5, its newest AI model, which the company calls its “smartest and most intuitive to use model” yet. The algorithm comes with increased capabilities in a multitude of ...

What looks to be the changelog for stable One UI 8.5 on Galaxy S25 has been posted online. The update will include Galaxy AI improvements, among other new features. We’re expecting the update to roll ...

The system represents an improvement in autonomous or agentic capability. GPT-5.5 “represents a step toward AI systems that can complete complex, multistep tasks on a computer without human guidance,” ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Eilish has also posted about her love for the song, and ...

The rapper was only able to play eight minutes with the Nanjing Monkey Kings Nicole Sweet/BAL/Basketball Africa League via Getty J. Cole was only able to play one game with the Chinese basketball ...

Johnson & Johnson beat first-quarter earnings expectations on Tuesday and raised its full-year forecast, as strong demand for cancer drug Darzalex and psoriasis treatment Tremfya more than offset a ...